Publications by authors named "Mario Roselli"

Claim this Profile
L
Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions.
Emilia Daghir-Wojtkowiak, Javier Alfaro, Michele Mastromattei, Aleksander Palkowski, Mark Stares, Mario Roselli

Front Digit Health· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric Properties of the Self Care Oral Anticancer Agents Index (SCOAAI).
Marco Di Nitto, Silvia Ucciero, Tatiana Bolgeo, Vincenzo Damico, Greta Ghizzardi, Mario Roselli

Semin Oncol Nurs· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Vitamin D Levels on Progression-Free Survival and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Alessandro Ottaiano, Bianca Arianna Facchini, Marialucia Iacovino, Mariachiara Santorsola, Sergio Facchini, Mario Roselli

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors.
Roberto Rosenfeld, Silvia Riondino, Giusy Parisi, Giovanni Maria Iannantuono, Rexhina Ajdhoni, Mario Roselli

Front Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in Italy.
Stefania Moramarco, Luigi De Angelis, Laura Bernardini, Lorenza Marconi, Gaia Piunno, Mario Roselli

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized Medicine.
Maria Cristina Rapanotti, Tonia Cenci, Maria Giovanna Scioli, Elisa Cugini, Silvia Anzillotti, Mario Roselli

Biomedicines· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing fencing as adapted physical activity in non-metastatic breast cancer patients: design and early rehabilitation strategy of the FENICE study protocol.
Massimiliano Berretta, Daniele Garozzo, Calogero Foti, Mario Roselli, Marco Materazzo

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for and Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study.
Carmine Pinto, Armando Orlandi, Nicola Normanno, Evaristo Maiello, Maria A Calegari, Mario Roselli

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?
Silvia Riondino, Roberto Rosenfeld, Vincenzo Formica, Cristina Morelli, Giusy Parisi, Mario Roselli

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials.
Giovanni Maria Iannantuono, Elias Chandran, Charalampos S Floudas, Hyoyoung Choo-Wosoba, Gisela Butera, Mario Roselli

Cancer Treat Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications of large language models in cancer care: current evidence and future perspectives.
Giovanni Maria Iannantuono, Dara Bracken-Clarke, Charalampos S Floudas, Mario Roselli, James L Gulley

Front Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC).
Cristina Morelli, Vincenzo Formica, Paolo Bossi, Michela Rofei, Simona Guerriero, Mario Roselli

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling.
Vincenzo Formica, Silvia Riondino, Cristina Morelli, Simona Guerriero, Federica D'Amore, Mario Roselli

Br J Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives.
Stefano Sganga, Silvia Riondino, Giovanni Maria Iannantuono, Roberto Rosenfeld, Mario Roselli

J Pers Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Content Validity of the Self-Care of Oral Anticancer Agents Index (SCOAAI).
Federica Lacarbonara, Marco Di Nitto, Valentina Biagioli, Angela Durante, Fabio Sollazzo, Mario Roselli

Semin Oncol Nurs· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis.
Vincenzo Formica, Cristina Morelli, Veronica Conca, Maria Alessandra Calegari, Jessica Lucchetti, Mario Roselli

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biospecimen Digital Twins: Moving from a "High Quality" to a "Fit-for-Purpose" Concept in the Era of Omics Sciences.
Umberto Nanni, Patrizia Ferroni, Silvia Riondino, Antonella Spila, Maria Giovanna Valente, Mario Roselli

Cancer Genomics Proteomics· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies.
Ombretta Melaiu, Gianluca Vanni, Ilaria Portarena, Chiara Adriana Pistolese, Lucia Anemona, Mario Roselli

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?
Silvia Riondino, Vincenzo Formica, Elena Valenzi, Cristina Morelli, Valeria Flaminio, Mario Roselli

Curr Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and Trastuzumab.
Marcello Chiocchi, Martina Cerocchi, Federica Di Tosto, Roberto Rosenfeld, Monia Pasqualetto, Mario Roselli

J Pers Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series.
Giovanni Maria Iannantuono, Silvia Riondino, Stefano Sganga, Roberto Rosenfeld, Simona Guerriero, Mario Roselli

J Pers Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer.
Cristina Morelli, Vincenzo Formica, Anna Patrikidou, Michela Rofei, Kai Keen Shiu, Mario Roselli

J Gastrointest Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer.
Giovanni Maria Iannantuono, Francesco Torino, Roberto Rosenfeld, Simona Guerriero, Manuela Carlucci, Mario Roselli

Int J Mol Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Valentina Russo, Eleonora Lallo, Armelle Munnia, Miriana Spedicato, Luca Messerini, Mario Roselli

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review.
Roberto Rosenfeld, Silvia Riondino, Vincenzo Formica, Francesco Torino, Eugenio Martuscelli, Mario Roselli

J Pers Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis